Metabolic rates in normal and infarcted myocardium

Prior research has shown that myocardial infarction alters cardiac metabolism. Established knowledge includes changes in substrate utilization after heart injury. This gap motivated a closer look at fatty acid and glucose oxidation in surviving tissue. No prior work had resolved how infarction affects metabolic pathways at different workloads. The study builds on known shifts in energy substrate preference. It addresses uncertainty about the accuracy of measuring oxidation rates using labeled substrates. The paper introduces a novel focus on the limitations of 14CO2 production as a proxy for true oxidative rates. This work expands on existing models of cardiac metabolism post-infarction.

The study aimed to evaluate how myocardial infarction affects fatty acid and glucose oxidation in non-infarcted tissue. Researchers focused on metabolic changes in the surviving myocardium after a rat infarction. They sought to determine if infarction alters substrate utilization at different cardiac workloads. The motivation stemmed from gaps in understanding post-infarction metabolic shifts. The experiment tested whether 14CO2 production accurately reflects true oxidation rates. Researchers also wanted to assess how endogenous fatty acid stores influence measurements. The study aimed to clarify if observed lower CO2 production meant lower oxidation or altered turnover. This work sought to refine methods for measuring cardiac metabolic rates.

The researchers used rat hearts one week post-infarction in an isolated working heart setup. Oxygen consumption and substrate oxidation were measured at two workloads. They tracked palmitate and glucose oxidation using [14C]-labeled substrates. 14CO2 production was used to estimate oxidation rates. The study considered limitations in using this method for long-chain fatty acids. They examined whether intracellular metabolite specific activity equilibrated with extracellular substrate. The model included comparisons between normal and infarcted hearts. The approach highlighted how endogenous fatty acid stores might skew measurements.

The study found that 14CO2 production may underestimate true oxidation rates for long-chain fatty acids. Lower CO2 output in infarcted hearts did not always mean reduced fatty acid oxidation. Differences in endogenous fatty acid turnover could explain the lower specific activity. At physiological concentrations, a shift to carbohydrate oxidation occurred in surviving tissue. The shift was observed in hypertrophied, non-infarcted regions after infarction. The results suggest that metabolic substrate preference changed post-infarction. The study revealed that substrate oxidation rates depend on workload and injury status. These findings highlight limitations in using CO2 production as a direct measure of oxidation.

The authors propose that 14CO2 production may not accurately reflect true fatty acid oxidation rates. They suggest that lower CO2 output could result from altered endogenous fatty acid turnover. The findings indicate a shift in substrate utilization after myocardial infarction. The study implies that workload influences metabolic substrate preference in surviving tissue. Researchers propose that metabolic changes occur in non-infarcted regions after injury. The results suggest that existing methods may misrepresent true oxidation rates. The authors caution against interpreting lower CO2 production as reduced oxidation. These conclusions emphasize the need for refined methods to measure cardiac metabolism.